Mechanisms Of Esophageal Cancer Development In Brazilians

Esophageal cancer represents one of the most common and lethal cancers around the World. Some areas of South America, including parts of Brazil, present the highest incidence of the disease in the West. The main etiological factors that have been associated with the disease in Brazil are alcohol consumption, tobacco smoking and, in the South, consumption of hot maté. Nitrosamines are the only carcinogens capable of inducing tumors in the esophagus of experimental animals, with the rat being the most susceptible species, mainly due to tissue specific metabolic activation by CYP enzymes. Studies of CYP2A expression in the esophagus of rodents suggest an association between CYP2A expression and esophageal susceptibility to tumor induction. CYP2A6 and CYP2E1, the main enzymes to activate nitrosamines in humans, are the only carcinogen activating CYP enzymes to be expressed in the esophagus of Brazilians. Patients who presented high levels of CYP2A6 expression could activate nitrosamines at rates comparable to the rat. This expression profile is different from those present in French patients. We investigated 34 Brazilian patients regarding the risk associated with polymorphisms in drug metabolizing enzymes and TP53 mutations. A GSTP1 polymorphism presented a clear risk to white and non-white patients to develop esophageal cancer. GSTM1 null polymorphism also seemed to be associated with an increased risk. CYP2A6, CYP2E1, SOD2, and GSTT1 polymorphisms were not associated with an increased risk of esophageal cancer. TP53 mutations occurred mostly in exon 7, differing from the mutation profile found in the IARC database. The preliminary results obtained with polymorphisms of drug metabolizing enzymes and TP53 mutations need to be confirmed in a larger number of samples in order to compare the mechanisms of esophageal cancer development in Brazilians with that of other populations. © 2003 Elsevier B.V. All rights reserved.54402/03/15365373Parkin, D.M., Pisani, P., Ferlay, J., Estimates of the World wide incidence of the 25 major cancers in 1990 (1999) Int. J. Cancer, 80, pp. 827-841Allen, J.W., Richardson, J.D., Edwards, M.J., Squamous cell carcinoma of the esophagus: A review and update (1997) Surg. Oncol., 6, pp. 193-200Craddock, V.M., (1993) Cancer of the Esophagus, , Cambridge University Press, Cambridge, UKYang, C.S., Research on esophageal cancer in China: A review (1980) Cancer Res., 40, pp. 2633-2644Esophageal cancer studies in the caspian litoral of Iran: results of population study - a prodrome (1977) J. Natl. Cancer Inst., 59, pp. 1127-1138(2003), http://www.inca.gov.br, Brazilian Health Ministry, Estimativas da Incidência e Mortalidade por Câncer no Brasil, Instituto Nacional do Câncer (INCA), Ministério da SaúdeWaterhouse, J.A.H., Muir, K., Shanmugatnam, K., Powell, J., Cancer Incidence in the Five Continents, IV. , International Agency for Research on Cancer, Lyon, 1982Prolla, J.C., Dietz, J., Da Costa, L.A., Diferenças Geográficas na mortalidade por câncer de esôgfago no Rio Grande do Sul (1993) Rev. Ass. Med. Brasil., 39, pp. 217-220Corley, D.A., Buffler, P.A., Oesophageal and gastric cardia adenocarcinomas: Analysis of regional variation using the Cancer Incidence in Five Continents database (2001) Int. J. Epidemiol., 30, pp. 1415-1425Castellsagué, X., Muñoz, N., De Stefani, E., Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women (1999) Int. J. Cancer, 82, pp. 657-664Castellsagué, X., Muñoz, N., De Stefani, E., Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America (2000) Int. J. Cancer, 8, pp. 658-664Gimeno, S.G.A., De Souza, J.M.P., Mirra, A.P., Fatores de Risco para o câncer de esôfago: Estudo caso-controle em área metropolitana da regiãp Sudeste do Brasil (1995) Ver. Saúde Pública, 29, pp. 159-165Bouchardy, C., Khlat, M., Mirra, A.P., Parkin, D.M., Cancer risks among European migrants in São Paulo Brazil (1993) Eur. J. Cancer, 29 A, pp. 1418-1423Magee, P.N., The experimental basis for the role of nitroso compounds in human cancer (1989) Cancer Surv., 8, pp. 207-239Lijinsky, W., (1992) Chemistry and Biology of N-Nitroso Compounds, , Cambridge University Press, Cambridge, UKSwann, P.F., The possible role of nitrosamines in the link between alcohol consumption and esophageal cancer in man (1984) Toxicol. Pathol., 12, pp. 357-360Yang, C.S., Smith, Y., Ishizaki, H., Hong, J.Y., Enzyme mechanisms in the metabolism of nitrosamines (1991) Relevance to Human Cancer of N-Nitroso Compounds, Tobacco Smoke and Mycotoxins, pp. 265-274. , I.K. O'Neill, J. Chen, H. Barysch (Eds.). International Agency for Research on Cancer, LyonRibeiro Pinto, L.F., Differences between isoamyl alcohol and ethanol on the metabolism and DNA ethylation of N-nitrosodiethylamine in the rat (2000) Toxicology, 151, pp. 73-79Gibel, W., Experimentelle untersuchungen zur syncarcinogenese beim oesophaguscarzinom (1967) Arch. Gerchwulstforsch, 30, pp. 181-189Ribeiro Pinto, L.F., Swann, P.F., Opium and oesophageal cancer: Effect of morphine and opium on the distribution of N-nitrosodimethylamine and N-nitrosodiethylamine in the rat (1997) Carcinogenesis, 18, pp. 365-369Ribeiro Pinto, L.F., Moraes, E., Albano, R.M., Rat oesophageal cytochrome P450 (CYP) monooxygenase system: Comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis (2001) Carcinogenesis, 22, pp. 1877-1883Patterson, C.J., Peterson, L.A., Murphy, S.E., Evidence for metabolic activation of N-nitrosonornicotine and N-nitrosomethylbenzylamine by rat nasal coumarin hydroxylase (1998) Drug Metab. Dispos., 26, pp. 177-180Chen, S.C., Wang, X., Xu, G., Depentylation of ( 3H pentyl)methyl-n-amylnitrosamine by rat oesophageal and liver microsomes and by rat and human cytochrome P450 isoforms (1999) Cancer Res., 59, pp. 91-98Godoy, W., Albano, R.M., Moraes, E.G., CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: Regional and inter-individual variation in expression and relevance to nitrosamine metabolism (2002) Carcinogenesis, 23, pp. 611-616Raunio, H., Rautio, A., Pelkonen, O., The CYP2A subfamily: function, expression, and genetic polymorphism (1999) Metabolic Polymorphisms and Susceptibility to Cancer, pp. 197-208. , P. Vineis, N. Malats, M. Lang, A. d'Errico, N. Caporaso, J. Cuzick, P. Bofetta (Eds.). International Agency for Research on Cancer, LyonLechevrel, M., Casson, A.G., Wolf, C.R., Characterization of cytochrome P450 expression in human oesophageal mucosa (1999) Carcinogenesis, 20, pp. 243-248Robottom, A.B., Aquino, S., Queiroga, R., Expression of CYP2A3 mRNA and its regulation by 3-methylcholanthrene, pyrazole, and B-ionone in different tissues of the rat (2003) Braz. J. Med. Biol. Res., 36, pp. 839-844Montesano, R., Hollstein, M., Hainaut, P., Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review (1996) Int. J. Cancer, 69, pp. 1-11Lam, A.K.Y., Molecular biology of esophageal squamous cell carcinoma (2000) Crit. Rev. Oncol./Hematol., 33, pp. 71-90Olivier, M., Eeles, R., Hollstein, M., The IARC TP53 database: New online mutation analysis and recommmendations to users (2002) Hum. Mutat., 19, pp. 607-614Pütz, A., Hartmann, A.A., Fontes, P.R.O., TP53 mutation pattern of esophageal squamous cell carcinoma in a high risk area (Southern Brazil): Role of life style factors (2002) Int. J. Cancer, 98, pp. 99-105Pfeifer, G.P., Hainaut, P., On the origin of G→T transversions in lung cancer (2003) Mutat. Res., 526, pp. 39-43Hayashi, S., Watanabe, J., Kawajiri, K., Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene (1991) J. Biochem., 110, pp. 559-565Wang, S., Lee, H., Chen, K., Cytochrome P4502E1 genetic polymorphisms and lung cancer in taiwanese population (1999) Lung Cancer, 26, pp. 27-34Morita, S., Yano, M., Shiozaki, H., CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus (1997) Int. J. Cancer, 71, pp. 192-195Tan, W., Song, N., Wang, G., Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high risk individuals in CHN (2000) Cancer Epidemiol. Biomarkers Prev., 9, pp. 551-556Van Lieshout, E.M.M., Roelofs, H.M.J., Dekker, S., Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barretts esophagus and esophageal carcinoma (1999) Cancer Res., 59, pp. 586-589Van Lieshout, E.M.M., Van Haelst, U.J.G.M., Wobbes, T., Peters, W.H.M., Immunohistochemical localization of glutathione S-transferase A and P in human esophageal squamous epithelium, Barrett's epithelium and carcinoma (1999) Jpn. J. Cancer Res., 90, pp. 530-535Harries, L.W., Stubbins, M.J., Forman, D., Identification of gentic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer (1997) Carcinogenesis, 18, pp. 641-644Abdel-Rahman, S.Z., El-Zhein, R.A., Anwar, W.A., Au, W.W., A multiplex PCR procedure for polymorphic analysis of GSTM1 and 0 genes in population studies (1996) Cancer Lett., 107, pp. 229-233Shimoda-Matsubayashi, S., Matsumine, H., Kobayashi, T., Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene (1996) Biochem. Biophys. Res. Commun., 226, pp. 561-565Ahomadegbe, J.C., Barrois, M., Fogel, S., High incidence of TP53 alterations (mutations, deletion, overexpression) in head and neck primary tumors and metastasisAbsence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and early non-invasive lesions (1995) Oncogene, 10, pp. 874-879Lee, J.S., Alternative dideoxy sequencing of double-strand DNA by cyclic reactions using Taq polymerase (1991) DNA Cell. Biol., 10, pp. 67-7